drugset / Trial / NCT05253846
Short-course Radiotherapy Followed by Consolidation Chemotherapy. 2021-001206-29
NaSingle-groupOpen-labelTreatment
Summary
The aim of the ShorTrip trail is to evaluate the activity and the safety of total neoadjuvant strategy with FOLFOXIRI as consolidation therapy preceded by short-course radiotherapy and followed by surgery in LARC patients.
Timeline
- Start
- 2022-01-25
- Primary completion
- 2025-01-05
- Completion
- 2028-10-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Irinotecan | Small molecule | 165 mg/m2 | Intravenous |
| Subject | Lederfolin | Unknown | 200 mg/m2 | Intravenous |
| Subject | Oxaliplatin | Small molecule | 85 mg/m2 | Intravenous |
| Subject | fluorouracil | Small molecule | 3200 mg/m2 | — |
Indications
No indication recorded.